Yazhao Li

No. 277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Hepatic Stellate Cells Antagonize Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Upregulating the LINC00152/HSPB1 Axis.

Hepatic Stellate Cells Antagonize Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Upregulating the LINC00152/HSPB1 Axis.

Journal: Cancers
Published: May 14, 2026

Polarity protein MALS3 suppresses breast cancer stem cell-like properties by promoting TAZ inactivation and ubiquitination-dependent degradation.

Polarity protein MALS3 suppresses breast cancer stem cell-like properties by promoting TAZ inactivation and ubiquitination-dependent degradation.

Journal: Cell death & disease
Published: January 22, 2026

CDT1 induces the formation of polyploid giant cancer cells and promotes centrosome amplification through the PLK4/SASS6 axis.

CDT1 induces the formation of polyploid giant cancer cells and promotes centrosome amplification through the PLK4/SASS6 axis.

Journal: Cancer letters
Published: June 15, 2025

A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41.

A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41.

Journal: BMC cancer
Published: March 28, 2025

EIF4A3 Promotes Cell Proliferation via CDC5L Upregulation in Human Breast Cancer Cells.

EIF4A3 Promotes Cell Proliferation via CDC5L Upregulation in Human Breast Cancer Cells.

Journal: Journal of Cancer
Published: December 16, 2024

S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs.

S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs.

Journal: Oncoimmunology
Published: July 29, 2024

Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.

Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: March 28, 2024

BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex.

BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex.

Journal: Cancer immunology, immunotherapy : CII
Published: July 08, 2023

Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types.

Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types.

Journal: Cancer science
Published: April 29, 2022

Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.

Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.

Journal: Clinical and translational medicine
Published: November 28, 2020

High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway.

High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway.

Journal: Journal of Cancer
Published: March 14, 2020

MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.

MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.

Journal: Artificial cells, nanomedicine, and biotechnology
Published: September 29, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026